Brief: Emmaus Life Sciences Receives FDA Approval For Endari® Label Enhancements
26/06/2025 15:37
June 26 (Reuters) - Emmaus Life Sciences Inc EMMA.PK: EMMAUS LIFE SCIENCES RECEIVES FDA APPROVAL FOR ENDARI® LABEL ENHANCEMENTS Source text: ID:nPn6VQtJCa Further company coverage: EMMA.PK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Emmaus Life Sciences
See all newsEmmaus Life Sciences Q2 revenue soars on licensing deal
Emmaus Life Sciences Q1 revenue falls driven by lower sales in U.S.
Brief: Emmaus Life Sciences Enters License And Distribution Agreement With Neoimmunetech
Emmaus Life Sciences Q3 revenue falls 38%, swings to loss
Brief: Emmaus Life Sciences CFO Yasushi Nagasaki Resigns